Microvascular decompression compared with other surgical interventions for trigeminal neuralgia: A systematic review and meta-analysis
In brief
Microvascular decompression showed 79% long-term relief versus 55% with radiosurgery
Across mostly retrospective studies of medically refractory trigeminal neuralgia, microvascular decompression was associated with higher long-term pain relief than stereotactic radiosurgery, and with fewer recurrences; relief rates were similar to balloon compression. These crude comparisons are limited by nonrandomized studies, baseline differences and varied follow-up, so they cannot establish which procedure offers more durable relief.
- Journal
- Neurosurgical review (Q1)
- Published
- 18 November 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Shaun A Nguyen, Kaiwen Chen, Cali Loblundo, Jacqueline P Nguyen, Warren Chun, Sunil Patel, et al.
- PMID
- 43049822
- DOI
- 10.1007/s10143-026-04594-2
Why clinicians should know about it
- Picked for Radiation Oncology (top studies of the week, 22 November 2026): Compares stereotactic radiosurgery with surgical trigeminal neuralgia treatments
Abstract
Microvascular decompression (MVD) is often considered the standard of care operation for medically refractory primary trigeminal neuralgia (PTN), yet there is variable evidence comparing its effectiveness with other procedures such as percutaneous balloon compression (PBC) or stereotactic radiosurgery (SRS). Following PRISMA guidelines, we systematically searched CINAHL, Cochrane Library, Embase, PubMed, and Scopus from inception through April 1, 2026. Studies of surgically naïve PTN patients undergoing procedural and surgical interventions for PTN comparing MVD with at least one other procedural or surgical intervention were included. Outcomes focused on pain relief, recurrence, repeat procedures, and complications. A total of 26 studies (7 prospective, including two randomized controlled trials, and 19 retrospective) comprising 3,806 patients were included. Across predominantly retrospective cohorts, MVD was associated with higher short‑term and long‑term pain relief and lower crude recurrence and reoperation rates than SRS (e.g., short‑term 94.7% vs. 67.3%; long‑term 79.4% vs. 55.4%; recurrence 9.5% vs. 32.0%). Versus RFR, MVD showed higher short‑term (89.0% vs. 68.5%) and long‑term pain relief (72.1% vs. 54.7%), with lower crude recurrence (20.7% vs. 38.3%) and fewer repeat procedures (10.7% vs. 53.5%). MVD and PBC demonstrated similar short‑term (89.3% vs. 91.8%) and long‑term relief (83.9% vs. 79.7%), whereas crude recurrence rates favored MVD (11.1% vs. 18.3%). Limited data suggested higher long‑term pain relief with MVD versus partial sensory rhizotomy (88.9% vs. 70.9%). MVD generally showed lower rates of persistent sensory complications than ablative or radiosurgical procedures. These patterns arise largely from nonrandomized studies with baseline imbalances and variable follow‑up. Recurrence and long‑term estimates are crude proportions without time‑to‑event adjustment and are therefore exploratory and descriptive. This systematic review and meta-analysis suggests that MVD is an important option for appropriately selected PTN patients, with observational comparative data showing higher crude long‑term pain relief, lower crude recurrence, and fewer persistent sensory complications than several alternatives. Given the predominance of retrospective, nonrandomized cohorts and heterogeneous follow‑up, the pooled recurrence and long‑term estimates are exploratory descriptive findings and cannot establish comparative durability or superiority of MVD over alternative interventions.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.